<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: GlaxoSmithKline profits up 36% &#8211; warnings for 2019	</title>
	<atom:link href="https://ukinvestormagazine.co.uk/glaxosmithkline-profits-up-36-warnings-for-2019/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestormagazine.co.uk/glaxosmithkline-profits-up-36-warnings-for-2019/</link>
	<description>UK Investor Magazine provides breaking financial news and investment ideas</description>
	<lastBuildDate>Tue, 03 Sep 2024 14:39:07 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.5</generator>
	<item>
		<title>
		By: Temple Bar Investment Trust performance slips with volatility - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/glaxosmithkline-profits-up-36-warnings-for-2019/#comment-31220</link>

		<dc:creator><![CDATA[Temple Bar Investment Trust performance slips with volatility - UK Investor Magazine]]></dc:creator>
		<pubDate>Tue, 03 Sep 2024 14:39:07 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=18194#comment-31220</guid>

					<description><![CDATA[[&#8230;] the end of December, the firm&#8217;s top holdings were GlaxoSmithKline (LON:GSK), Shell(AMS:RSDA), Capita (LON:CPI), BP (LON:BP) and Travis Perkins (LON:TPK). After a modest rally [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] the end of December, the firm&#8217;s top holdings were GlaxoSmithKline (LON:GSK), Shell(AMS:RSDA), Capita (LON:CPI), BP (LON:BP) and Travis Perkins (LON:TPK). After a modest rally [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Indivior releases new treatment, shares dip with copycat fears - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/glaxosmithkline-profits-up-36-warnings-for-2019/#comment-9606</link>

		<dc:creator><![CDATA[Indivior releases new treatment, shares dip with copycat fears - UK Investor Magazine]]></dc:creator>
		<pubDate>Wed, 20 Feb 2019 11:17:06 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=18194#comment-9606</guid>

					<description><![CDATA[[&#8230;] firms outperforming other sectors in 2018 and enjoying a positive start to 2019 &#8211; though some fears surround the longevity of profits as the year goes [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] firms outperforming other sectors in 2018 and enjoying a positive start to 2019 &#8211; though some fears surround the longevity of profits as the year goes [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
